Relationship between synovial versus skin transcriptional/histological profiles in patients with active psoriatic arthritis treated with ustekinumab or anti-TNF
Latest Information Update: 20 Jan 2021
At a glance
- Drugs Ustekinumab (Primary) ; Tumour necrosis factor inhibitors
- Indications Psoriatic arthritis
- Focus Pharmacodynamics; Pharmacogenomic
- 20 Jan 2021 New trial record